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INTRODUCTION
Hypereosinophilia is an abnormal condition defined by
the presence of more than 500 eosinophils per microliter of
blood. Hypereosinophilia occurs in allergic reactions, helmi-
nthic infestation, collagen vascular disease and malignancies
etc. (1, 2). The diagnosis of the idiopathic hypereosinophilic
syndrome is based on exclusion of other causes of hyper-
eosinophilia. That is a disease characterized by unexplained
hypereosinophilia persisting for at least 6 months and lead-
ing to organ damage (3).
The most common cutaneous manifestations in idiopathic
hypereosinophilic syndrome are either erythematous, pruritic
papules and nodules or angio-edematous and urticarial plaques.
In previous reports, cases with cutaneous vasculitis including
eosinophilic infiltration involving small dermal vessel were
described (4, 5). Eosinophilic vascular inflammation of those
cases showed good response to glucocorticoid treatment.
We report here a case with hypereosinophilia and peripheral
artery occlusion. It differs from cutaneous eosinophilic vas-
culitis and particularly has no internal organ involvement.
This case has many differences from typical idiopathic hyper-
eosinophilic syndrome.
CASE REPORT
A 32-yr-old Korean woman presented with lower extremity
swelling and pain.
One year and three months ago, she developed swelling
and itching sense in both lower extremities. She visited an
orthopedic clinic and was prescribed antibiotics with the
impression of having a cellulitis for 1 month. But, this swelling
progressed to her both hands and pain was developed. Bluish
discoloration then appeared at both hands and legs together
with necrosis at some areas. Laboratory investigations revealed
a persistent hypereosinophilia (9,374-16,358/ L). Lower
extremity CT angiography showed that multiple lower ex-
tremity arteries were occlusive. A biopsy specimen from her
foot showed perivascular and periadnexal dense eosinophilic
infiltration in dermis and subcutaneous adipose tissue. Bone
marrow finding showed reactive eosinophilia. We performed
microscopic stool exam, ELISA for parasitic antibody, skin
prick test for common allergens and bronchial provocation
test. She had no evidence of parasitic, allergy, connective tis-
sue disease or other known causes of eosinophilia. She was
prescribed oral prednisolone 60 mg, aspirin 100 mg, clopi-
dogrel 75 mg, and beraprost (PGI) 60 mg daily. Her skin
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Hypereosinophilia Presenting as Eosinophilic Vasculitis and Multiple
Peripheral Artery Occlusions without Organ Involvement
We report here a case with hypereosinophilia and peripheral artery occlusion. A
32-yr-old Korean woman presented to us with lower extremity swelling and pain.
Angiography revealed that multiple lower extremity arteries were occlusive. The
biopsy specimen showed perivascular and periadnexal dense eosinophilic infiltration
in dermis and subcutaneous adipose tissue. Laboratory investigations revealed a
persistent hypereosinophilia. She was prescribed prednisolone 60 mg daily. Her skin
lesion and pain were improved and the eosinophil count was dramatically decreased.
After discharge, eosinophil count gradually increased again. Cyanosis and pain of
her fingers recurred. She had been treated with cyclophosphamide pulse therapy.
Her eosinophilia was decreased, but the cyanosis and tingling sense were progres-
sive. The extremity arterial stenoses were slightly progressed. Skin biopsy showed
perivascular eosinophilic infiltration in the dermis and CD40 ligand (CD40L) positive
eosinophilic infiltration. The serum TNF- was markedly increased. These results
suggest that CD40L (a member of TNF- superfamily) could play a role in the inflam-
matory processes when eosinophil infiltration and activation are observed. We pre-
scribed prednisolone, cyclophosphamide, clopidogrel, cilostazol, beraprost and
nifedipine, and she was discharged. 
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Accepted : 2 August 2004lesion and pain were improved and the eosinophil count was
dramatically decreased (12-92/ L). One month later after
discharge, eosinophil count gradually increased up to 3,465/
L again. Six months later after her discharge, cyanosis and
pain of her fingers recurred. A Doppler scan on the extremities
was carried, which showed no significant interval change. She
was treated with cyclophosphamide pulse therapy five times.
Her eosinophilia was then decreased to about 1,000/ L, but
the cyanosis and tingling sense were progressive. She received
a sympathectomy procedure by the thoracoscopic approach
in order to relieve her tingling sense.
She then visited our hospital and received re-evaluation.
Her fingertips were gangrenous (Fig. 1). CT angiography on
the upper extremity and lower extremity was done. It showed
that the lower extremity arterial stenosis slightly progressed
compared with previous study and upper extremity arteries
below the wrist level had multiple stenosis (Fig. 2, 3). The
cerebral and carotid arteries were intact. Liver sonograpy, chest
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Fig. 1. Gross photograph: finger tips show gangrenous changes. Fig. 3. Upper extremity CT angiography; multiple stenosis are seen
in the upper extremity arteries below wrist level.
Fig. 4. Skin biopsy: Immunohistochemistry show CD40L positive
eosinophilic infiltration (×400).
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Fig. 5. Serum TNF- level compared with healthy controls and
other hypereosinophilia without vasculitis.
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Fig. 2. Lower extremity CT angiography; occlusions of right popliteal
artery, right posterior tibial artery, right peroneal artery, left posterior
tibial, left peroneal artery, left distal anterior tibial artery are seen.radiography and echocardiography showed no remarkable
finding. Skin biopsy showed perivascular eosinophilic infil-
tration in the dermis and CD40 ligand (CD40L) positive
eosinophilic infiltration (Fig. 4). The TNF- was markedly
increased more than that of several age-matched healthy per-
sons and other hypereosinophilia patient without vasculitis
(Fig. 5).
We judged that her disease had not remitted. We prescribed
prednisolone 60 mg, cyclophosphamide 50 mg a day and
other drugs such as clopidogrel, cilostazol, beraprost (PGI),
and nifedipine, and she was discharged from the hospital.
However, further follow-up is needed to evaluate whether
symptoms and signs change.
DISCUSSION
This case has several important characteristics. In most
other cases of eosinophilic vasculitis, they are characterized
as a glucocorticoid-responsive disorder (4, 6). Yet in this case,
although the eosinophil count was decreased after glucocor-
ticoid therapy, vascular occlusion was recurrent and progres-
sive. What is worse, it was persistent after cyclophosphamide
therapy. This case involved the relatively medium-sized ves-
sels (popliteal artery, tibia artery, peroneal artery, posterior
tibia and proximal superior mesenteric artery). This is a unique
feature distinctive from previous reported eosinophilic vasculi-
tis (5, 7, 8). Also, there is no evidence of multi-organ involve-
ment in this case, and this differs from typical idiopathic hy-
pereosinophilic syndrome (9).
Takegawa et al. have described an idiopathic hypereosino-
philic syndrome patient with fingertip necrosis and they sug-
gested that tumor necrosis factor (TNF) might play a part
in the mechanism (6). CD40 is the receptor for a CD40L, a
35-kDa glycoprotein and a member of the TNF- superfamily.
CD40L, which can be expressed by T cells, mast cells and
basophils, has been shown to be involved in the control of B
cell proliferation and immunoglobulin class switching, as
well as in the activation of monocytes and T cells (10). Gauchat
et al. have demonstrated that CD40L can also be expressed
constitutively by eosinophils from hypereosinophilic patients
(11). Eosinophils were able to induce, in conjunction with
IL-4, CD40L-dependent B cell proliferation in vitro. In this
case, immunohistochemistry for CD40L revealed that almost
all the eosinophils were stained by anti-CD40L monoclonal
antibody, and namely CD40L was elevated in tissue. TNF-
in the serum also was dramatically elevated. 
The results in this case suggest that CD40L could play a
role in the inflammatory processes when eosinophil infiltra-
tion and activation are observed, but fine mechanism is still
unclear. Further study which elucidates a specific role of the
interaction between CD40L and CD40 will be necessary. In
clinician’s view, factors which decide a steroid responsiveness
and involving vessel should be clarified.
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